Join us for the 2024 Judy Dunn International Conference, ‘Advancing ADHD Care: Evidence-Based Approaches in Child and Adolescent Mental Health’. Don’t miss this opportunity to stay at the forefront of ADHD care. Register now to secure your spot in this invaluable professional development experience.
Booking
Sign up at this link or on the Book Now button at the top of the screen, and complete the form that follows. You’ll then receive an email confirmation and a link to the webinar, plus we’ll send you a calendar reminder nearer the time. Delegates will have exclusive access to recordings for 90 days after the event, together with slides. Plus you will get a personalised CPD certificate via email.
- ACAMH Members MUST login to book onto the webinar in order to access this webinar and get a CPD certificate
- Non-members this is a great time to join ACAMH, take a look at what we have to offer, and make the saving on these sessions
EARLY BIRD
ACAMH Members £79 Early Bird, then £99 from Tuesday 8 October
Non Members £119 Early Bird, then £139 from Tuesday 8 October Join now and save
£5 Undergraduate / Postgraduate Members
FREE for ACAMH Low and Middle Income Countries Members
Don’t forget as a charity any surplus made is reinvested back as we work to our vision of ‘Sharing best evidence, improving practice’, and our mission to ‘Improve the mental health and wellbeing of young people aged 0-25’.
About the day
- Gain valuable insights into the latest research on ADHD causes, with a special focus on genetic factors. Clinicians will learn how to apply this knowledge to improve patient care and treatment planning.
- Explore current best practices in ADHD diagnosis, including new assessment tools and techniques. This session will provide practical guidance for conducting thorough and accurate evaluations.
- Discover evidence-based non-pharmacological treatments for ADHD, including behavioural therapies, cognitive training, and lifestyle modifications. Learn how to integrate these approaches into comprehensive treatment plans.
- Review the latest research on ADHD medications, their efficacy, and safety profiles. Our experts will discuss how to optimise pharmacological interventions based on individual patient needs.
- Examine the concept of neurodiversity and its implications for mental health conditions. Our speakers will delve into the benefits and challenges of incorporating neurodiversity perspectives into clinical work with children and adolescents.
Why attend?
- Gain practical knowledge from leading researchers and clinicians
- Learn about the latest evidence-based interventions for ADHD
- Enhance your diagnostic and treatment skills
- Explore neurodiversity and mental health
Who should attend
This is essential for mental health professionals, educators, and researchers working with children and adolescents with ADHD.
Programme (subject to change)
10:15 – Welcome and Introduction
10:20 – Is the concept of neurodiversity useful in clinical practice or neurodiversity and mental health conditions. Dr. Giorgia Michelini
10:50 – Discussion and questions.
11:35 – Break
11:45 – Update on causes of ADHD and what clinicians should know about the genetics of ADHD. Professor Anita Thapar
12:15 – Q&A
12:25 – Lunch
13:25 – Speaker TBC
13:55 – Q&A
13:55 – Non pharmacological treatments. Professor David Daley
14:25 – Q&A
14:35 – Break
14:45 – Pharmacological treatment Evidence base informing clinical practice. Professor Sam Cortese
15:15 – Q&A
15:25 – Closing Remarks
16:00 – End
About the speakers
Professor Samuele Cortese, MD, PhD is currently Professor of Child and Adolescent Psychiatry at the University of Southampton and Honorary Consultant Child and Adolescent Psychiatry for Solent NHS Trust. He is also Adjunct Full Professor with the New York University (NYU). Prof. Cortese’s main research interest are around neurodevelopmental disorders, with a focus on ADHD. In his research, he uses advanced evidence synthesis methods to address clinically relevant questions. He has published more than 350 peer-review papers and secured external funding as main or co-applicant for more than £ 13M. In 2022, Prof. Cortese was included in the list of the world’s most influential researchers of the past decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations in the field of psychiatry/psychology in 2021 in Web of Science. In 2022, he ranked #1 worldwide in terms of expertise on Attention-Deficit/Hyperactivity Disorder (ADHD) according to Expertscape.
I am a Professor Anita Thapar, a clinician scientist. My primary interests are in child neurodevelopmental disorders and depression. I was Lead Editor (Joint) of the 6th Edition of Rutter’s Child and Adolescent Psychiatry-the leading textbook for clinicians and scientists. I head the academic Child and Adolescent Psychiatry Section in the Division of Psychological Medicine and Clinical Neurosciences and the developmental disorders group within the MRC Centre for Neuropsychiatric Genetics and Genomics and Division. I also have honorary NHS consultant contracts with Cwm Taf and Cardiff and Vale UHBs.
Dr. Giorgia Michelini is a Lecturer (Assistant Professor) in Psychology at Queen Mary University of London and a Visiting Researcher at King’s College London and at the University of California Los Angeles (UCLA). After completing a BSc in Psychology and MSc in Clinical Psychology, she pursued a PhD in Developmental Psychopathology and Neuroscience at King’s College London, supervised by Professor Jonna Kuntsi. Her PhD work was awarded the 2018 Elsevier Outstanding Doctoral Thesis Prize and the 2018 Neil O’Connor Prize from the British Psychological Society. She then completed postdoctoral fellowships in the US at SUNY Stony Brook and UCLA, before returning to the UK to take up her current position. Her research seeks to elucidate the biological and psychosocial processes underlying neurodevelopmental (e.g., ADHD) and affective disorders, as well as their co-occurrence, in order to inform prevention, early identification, and treatment strategies. Her work has been supported by the National Institute of Heath Research, Brain and Behavior Research Foundation (NARSAD) and Klingenstein Third Generation Foundation.
Professor David Daley is a specialist in Psychological Intervention and Behaviour Change at the University of Nottingham. He heads the Children and Young People’s Theme and serves as Head of Applied Psychological Practice at Nottingham Trent University since July 2022. With a background in Applied Psychology, including a Ph.D. in Developmental Psychopathology, he leads the Neurodevelopmental theme at MindTech, a national center for mental healthcare and dementia technology. His research centers on enhancing parenting experiences for Neurodevelopmental Disorder families and environmental modification for ADHD. With over 160 academic papers and two books, he’s currently developing a digital sleep intervention for children with ADHD, collaborating with the Institute of Mental Health’s CANDAL and NIHR MindTech.
Booking
Sign up at this link or on the Book Now button at the top of the screen, and complete the form that follows. You’ll then receive an email confirmation and a link to the webinar, plus we’ll send you a calendar reminder nearer the time. Delegates will have exclusive access to recordings for 90 days after the event, together with slides. Plus you will get a personalised CPD certificate via email.
- ACAMH Members MUST login to book onto the webinar in order to access this webinar and get a CPD certificate
- Non-members this is a great time to join ACAMH, take a look at what we have to offer, and make the saving on these sessions
EARLY BIRD
ACAMH Members £79 Early Bird, then £119 from Tuesday 8 October
Non Members £99 Early Bird, then £139 from Tuesday 8 October Join now and save
£5 Undergraduate / Postgraduate Members
FREE for ACAMH Low and Middle Income Countries Members
Don’t forget as a charity any surplus made is reinvested back as we work to our vision of ‘Sharing best evidence, improving practice’, and our mission to ‘Improve the mental health and wellbeing of young people aged 0-25’.